Private equity in ophthalmology: taking the long view

Area of Science:

• Ophthalmology
• Healthcare Management
• Health Economics

Background:

• Private equity investment is rapidly consolidating ophthalmology and optometry practices.
• This trend raises concerns regarding the impact on healthcare delivery and patient outcomes.
• Understanding the financial and clinical implications is crucial for stakeholders.

Purpose of the Study:

• To review the growing implications of private equity (PE) activity in ophthalmology.
• To analyze empirical findings on PE's effects on practice operations and patient care.
• To examine legal and policy responses to PE investment in healthcare.

Main Methods:

• Literature review of empirical findings on private equity in ophthalmology.
• Analysis of studies on practice consolidation and financial performance.
• Examination of workforce changes and regulatory developments.

Main Results:

• PE investment often increases spending and utilization, with limited evidence of commensurate patient health benefits.
• Acquired practices may experience increased physician turnover, indicating workforce flux.
• Regulatory oversight of PE in healthcare is intensifying.

Conclusions:

• Ophthalmologists must consider the long-term effects of private equity transactions.
• Due diligence in selecting PE partners is essential to protect clinical decision-making and physician autonomy.
• Anticipating policy changes is vital for practices contemplating PE sales.